Patent · US Active

Pluripotent stem cell assay

US11591571B2 · kind B2 · utility

0Cited by

0References

14Claims

0Family size

Assignee

CYNATA THERAPEUTICS LIMITED · AU

Inventors

Igor I. Slukvin · Verona, US
Derek J. Hei · Concord, US
DIANA DRIER · Madison, US

Key dates

Filing date	Nov 15, 2017
Grant date	Feb 28, 2023
Priority date	—
Expiry date	Apr 1, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a method for detecting residual, undifferentiated pluripotent stem cells (PSCs) in a culture of cells differentiated from PSCs, the method comprising:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.